Navigation Links
Schizophrenia Gene May Have On/Off Switch
Date:9/11/2007

Mouse study suggests new target for treatment, reseachers say

TUESDAY, Sept. 11 (HealthDay News) -- Working with a mouse model of schizophrenia, researchers believe they may have found the disease's genetic on/off switch.

Understanding how this gene works could lead to the development of better treatments, the team said.

Researchers at Johns Hopkins University, Baltimore, developed a mouse model for schizophrenia by inserting the mutant Disrupted-In-Schizophrenia (DISC-1) gene into a normal mouse, along with a promoter that allows the gene to switch on or off.

Mutant DISC-1 was identified in a Scottish family with a strong history of schizophrenia and related disorders. The researchers found they could turn the gene off by feeding the mice a nontoxic chemical that affects the production of DISC-1 proteins.

The team also observed that male mice with the mutated gene were more active and aggressive than other mice. The gene also appeared to alter the mice's social interactions, and females with the mutated gene were less able to remember how to get through a maze.

The mouse model is similar enough to schizophrenia in humans for the research to have implications for human mental illness, the scientists said.

"Schizophrenia is a human disorder, so we cannot say the symptoms displayed by the mouse model are schizophrenic. But they are in line with the kinds of behavioral changes we see in humans with schizophrenia," lead researcher Dr. Mikhail Pletnikov said in a prepared statement.

The researchers also examined the brains of the mutated mice using MRI scans. The scans showed significant enlargement of the lateral ventricles -- fluid-filled areas of the brain that are often enlarged in humans with schizophrenia.

The team also found abnormal brain cells in brain tissue from the part of the brain associated with schizophrenia.

The mutated mice also had abnormal levels of two proteins -- 25 kDa synaptosome-associated protein (SNAP-25) and lissencephaly-1, which are both known to be important to brain cell development and growth. Prior studies of human brain tissue has shown abnormal levels of SNAP-25 as well.

"This model supports the idea that schizophrenia is a disease associated with abnormal brain development," senior co-author of the study Dr. Christopher Ross said in a prepared statement. "Being able to regulate the timing of expression of the mutant protein provides an opportunity to study the timing and mechanism of specific abnormalities -- a tool that could eventually lead to the discovery of drugs that could potentially control or even prevent the disease," he said.

The study is published in the September issue of Molecular Psychiatry.

More information

To learn about schizophrenia, visit the National Alliance on Mental Illness.



-- Madeline Vann



SOURCE: Johns Hopkins University, news release, Sept. 10, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Identifying The Risks Of Developing Schizophrenia
2. Sex exploitation connected to Schizophrenia
3. Schizophrenia detected early
4. No explanation on schizophrenia gene
5. Gene glitches connecting pot with Schizophrenia
6. An insight about Schizophrenia
7. Risk Of Schizophrenia due to Gene Variation
8. Factors That Might Increase The Risk Of Schizophrenia
9. Dads Age Found To Affect The Childs Risk for Schizophrenia
10. Famine May Be A Cause For Schizophrenia
11. Schizophrenia Gets A New Diagnostic Tool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... , ... May 24, 2017 , ... ... of ExtraHop to its solutions portfolio. ExtraHop delivers an analytics-first approach, layered with ... every IT system, from the datacenter to the cloud to the edge. Through ...
(Date:5/24/2017)... ... 24, 2017 , ... The CFOs included on this list ... in the nation and help their organizations navigate the challenges in healthcare today. ... in developing successful hospital and health system strategy. , Becker's Hospital Review has ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), a ... today that its iClinic V12.2 solution has achieved approval from National Center for ... PCMH 2017 standards which emphasize team-based care with a significant focus on the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, May ... since 2009, according to a Workers Compensation Research Institute (WCRI) study, a contrast ... North Carolina System: CompScope™ Benchmarks, 17th Edition looks at indemnity and medical ...
(Date:5/23/2017)... ... 2017 , ... London, May 23, 2017: Walter Schindler, the Founder and Managing ... Guest Speaker and Contributor to a weeklong series of classes, meetings, field trips and ... , Walter Schindler and SAIL Capital have received an increasing number ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)... -- Bayer announced today that the latest research from across ... 53 rd Annual Meeting of the American Society ... Chicago . The ... and thyroid cancers, as well as lymphomas, and includes ... of copanlisib in patients with relapsed or refractory follicular ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: